Cargando…
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
BACKGROUND: The current study aimed to evaluate the efficacy of intravitreal aflibercept injections as the primary treatment for subfoveal/juxtafoveal myopic choroidal neovascularization (CNV) by using optical coherence tomography (OCT). Optical coherence tomography angiography (OCTA) was further us...
Autores principales: | Chen, Shih-Lin, Tang, Pei-Ling, Wu, Tsung-Tien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8459492/ https://www.ncbi.nlm.nih.gov/pubmed/34551746 http://dx.doi.org/10.1186/s12886-021-02088-x |
Ejemplares similares
-
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Wang, Jia-Kang, et al.
Publicado: (2018) -
High‑dose aflibercept injection has striking effects on myopic choroidal neovascularization
por: Zhu, Wei, et al.
Publicado: (2023) -
Comparison of Intravitreal Aflibercept and Ranibizumab for Treatment of Myopic Choroidal Neovascularization: One-Year Results—A Retrospective, Comparative Study
por: Erden, Burak, et al.
Publicado: (2019) -
Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017) -
Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization
por: Di Antonio, Luca, et al.
Publicado: (2018)